METABOLIC TECHNOLOGIES, INC.
This Small Business Innovation Research (SBIR) Phase I project aims to evaluate the use of a marine organism for production of the polyunsaturated fatty acid (PUFA), docosahexaenoic acid (DHA). DHA is ...SBIR Phase I 2013 National Science Foundation
DESCRIPTION (provided by applicant): Chronic alcohol overconsumption is the third largest risk factor for disease burden worldwide and is a frequent comorbidity of liver disease and cancer. While abst ...SBIR Phase I 2014 Department of Health and Human Services
DESCRIPTION (provided by applicant): Sarcopenia, defined as age related loss of muscle mass and muscle function and strength, is very prevalent among the elderly. Sarcopenia is one of the largest publ ...SBIR Phase II 2014 Department of Health and Human Services